Florian Müllershausen

What they invest in

Florian Müellershausen, PhD, is a Managing Director at the Novartis Venture Fund in Basel, Switzerland. He focuses on Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Seed), and BioTech (Series A). Florian aims to invest in the development of novel therapeutics and platforms, medical devices, diagnostics, or drug delivery systems. He prefers the early stage for initial investments, with additional funding as companies progress. Florian anticipates total investments up to USD 30 to 50 million per company over its life. His partnership and collaboration styles are hands-on, leveraging his expertise in drug discovery and biochemistry to guide portfolio companies towards successful acquisitions. Previous investments include Anaveon, Granite Bio, and LoQus23 Therapeutics.

Who works there

12 people on file: 12 with an email address, 12 with a phone number, 10 with a professional profile. Names and details are behind a free account.

No card. Each contact is charged once and stays yours.